Mitsui Chemicals (4183) AI Stock Analysis

• Market Cap: ¥612.23B
• Dividend Yield: 4.46%
• Average Volume (3M): 847.74K
• Price to Earnings (P/E): 18.9
• Beta (1Y): 1.16
• Revenue Growth: 3.40%
• EPS Growth: -35.14%
• Country: JP
• Employees: 19,861
• Sector: Basic Materials
• Sector Strength: 65
• Industry: Chemicals - Specialty
• EPS (TTM): -28.33
• Shares Outstanding: 200,843,810
• 10 Day Avg. Volume: 967,840
• 30 Day Avg. Volume: 847,740
• PEG Ratio: -0.33
• Price to Book (P/B): 0.83
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -17.91
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥4,100.67
• Price Target Upside: 27.35% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

• Rating: 68 Neutral
• Price Target: ¥3,461.00 ▲(7.48%Upside)

Mitsui Chemicals' overall stock score reflects a stable financial foundation with strong cash flow and moderate leverage. However, pressures on profitability and operational efficiency, coupled with a challenging earnings outlook, weigh on the score. While technical indicators are mixed, the valuation remains reasonable, supported by a solid dividend yield.

Mitsui Chemicals Business Overview & Revenue Model

Company Description

Mitsui Chemicals, Inc. (4183) is a leading Japanese chemical company engaged in the production and sale of a wide range of chemical products. The company's operations are divided into several sectors, including petrochemicals, basic chemicals, functional polymeric materials, and functional chemicals. Mitsui Chemicals provides innovative solutions across various industries, including automotive, healthcare, packaging, and electronics, through its diverse portfolio of high-performance materials and specialty chemicals.

How the Company Makes Money

Mitsui Chemicals generates revenue primarily through the manufacturing and sale of its extensive product line, which includes petrochemicals, basic chemicals, and high-performance materials. The petrochemicals segment, which involves the production of olefins and aromatics, forms a significant part of the company's revenue. Additionally, the company earns from its functional polymeric segment, delivering value-added plastics and elastomers used in automotive and packaging applications. The functional chemicals segment provides specialty chemicals for various applications, including healthcare and electronics, contributing to Mitsui's revenue. Strategic partnerships and collaborations with other companies in the industry, as well as a focus on research and development, further enhance its competitive position and revenue streams.

Mitsui Chemicals Financial Statement Overview

Summary

Mitsui Chemicals exhibits a solid financial foundation with strong cash flow dynamics, moderate leverage, and stable revenue growth. However, profitability margins face pressure, and return on equity has declined, presenting opportunities for operational efficiency improvements.

Income Statement

Mitsui Chemicals showed a mixed performance in recent years. The gross profit margin for 2025 was approximately 21.5%, indicating a reasonable level of profitability. However, the net profit margin decreased to 1.8% from the previous year, reflecting challenges in converting revenues into profits. Revenue growth in 2025 was about 3.4%, which is moderate. The EBIT margin was approximately 5.1%, and the EBITDA margin was 9.6%, both suggesting some pressure on operational efficiency. Overall, while profitability ratios are under pressure, the company maintains a stable revenue base.

Balance Sheet

The balance sheet reflects moderate financial leverage with a debt-to-equity ratio of approximately 0.87 in 2025. The equity ratio was about 39.4%, indicating a healthy proportion of equity financing. However, the return on equity decreased to 3.8%, suggesting diminished efficiency in generating returns for shareholders. Overall, the company's balance sheet remains stable with manageable debt levels, though profitability on equity could improve.

Cash Flow

Mitsui Chemicals demonstrated strong cash flow management with an operating cash flow to net income ratio of 6.22 in 2025, indicating robust operational cash generation relative to net income. The free cash flow grew significantly by over 900% compared to 2024, reflecting improved cash reserves after capital expenditures. The free cash flow to net income ratio was 2.46, showcasing effective cash retention post-investment activities. Overall, cash flow performance is a strong point for the company.

Breakdown
Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
1.81T	1.75T	1.88T	1.61T	1.21T
	Gross Profit
388.29B	370.80B	381.49B	378.74B	293.84B
	EBIT
92.94B	74.12B	129.00B	147.31B	78.07B
	EBITDA
173.69B	181.15B	182.81B	216.99B	157.75B
	Net Income Common Stockholders
32.24B	50.00B	82.94B	109.99B	57.87B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
170.62B	210.29B	262.72B	224.65B	223.16B
	Total Assets
2.15T	2.22T	2.07T	1.93T	1.56T
	Total Debt
737.98B	756.76B	738.25B	666.09B	510.22B
	Net Debt
567.36B	546.47B	551.94B	484.93B	314.23B
	Total Liabilities
1.18T	1.23T	1.18T	1.13T	875.97B
	Stockholders Equity
848.28B	862.85B	786.83B	712.65B	607.92B
Cash Flow		Free Cash Flow
79.29B	7.35B	-36.62B	-23.63B	97.74B
	Operating Cash Flow
200.50B	161.34B	101.24B	92.58B	174.32B
	Investing Cash Flow
-165.01B	-123.94B	-106.34B	-205.23B	-77.56B
	Financing Cash Flow
-74.44B	-26.02B	2.54B	89.22B	-68.96B

Mitsui Chemicals Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 3220.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4183, the sentiment is Neutral. The current price of 3220 is above the 20-day moving average (MA) of 3158.65, above the 50-day MA of 3127.64, and below the 200-day MA of 3362.36, indicating a neutral trend. The MACD of 26.83 indicates Negative momentum. The RSI at 55.24 is Neutral, neither overbought nor oversold. The STOCH value of 48.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4183.

Mitsui Chemicals Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4202	80 Outperform	¥321.11B	6.66	13.58%	4.80%	5.10%	-8.07%
4403	78 Outperform	¥638.76B	17.58	13.21%	2.03%	7.23%	8.93%
4118	73 Outperform	$244.55B	9.65	5.38%	3.20%	5.89%	11.92%
4182	71 Outperform	¥418.93B	9.43	6.78%	4.32%	-4.90%	20.59%
4183	68 Neutral	¥612.23B	18.88	3.69%	4.46%	3.40%	-35.14%
5201	63 Neutral	$909.03B	―	-4.41%	4.59%	1.96%	-399.31%
Sector *	51 Neutral	$2.04B	-1.15	-21.37%	3.64%	2.88%	-30.57%

Mitsui Chemicals Corporate Events

Mitsui Chemicals Plans Strategic Split to Boost Green Initiatives

Mitsui Chemicals is considering splitting off its Basic & Green Materials business to enhance its business structure and promote green initiatives. This strategic move aims to foster collaboration with other companies, improve competitiveness, and support Japan’s industrial competitiveness by creating a strong, independent green chemicals business entity by 2027.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Reports Decline in FY2024 Financial Results

Mitsui Chemicals announced a decline in its FY2024 non-consolidated financial results compared to the previous fiscal year. The company reported a decrease in ordinary and net income, primarily due to reduced operating income and dividend income, impacting its financial performance and potentially affecting stakeholder confidence.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Reports FY2024 Financial Shortfall

Mitsui Chemicals reported a shortfall in its FY2024 financial results compared to its previous forecasts. The decline was primarily due to decreased sales in the ICT Solutions segment and an impairment loss in the Life & Healthcare Solutions segment, along with increased income tax expenses. Despite these challenges, the company maintained its dividend forecast.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Reports 5% Increase in FY2024 Operating Income

Mitsui Chemicals reported a 5% increase in operating income before special items for FY2024, reaching 101.0 billion yen, driven by growth in specialty chemicals and successful sales price revisions in basic materials. Despite challenges such as an ethylene plant failure in Osaka, the company managed to offset losses through strategic business restructuring, indicating a strong market position and resilience.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Reports FY2024 Financial Results with Mixed Performance

Mitsui Chemicals reported its consolidated financial results for FY2024, showing a slight increase in sales revenue and operating income. Despite challenges in certain segments, the company saw growth in Life & Healthcare Solutions and Mobility Solutions. The organizational reforms and segment revisions implemented in April 2024 are expected to impact future performance positively. However, the company faced a decrease in net income and cash flow challenges, indicating a need for strategic adjustments to maintain financial stability.

The most recent analyst rating on (JP:4183) stock is a Sell with a Yen3650.00 price target. To see the full list of analyst forecasts on Mitsui Chemicals stock, see the JP:4183 Stock Forecast page.

Mitsui Chemicals Completes Acquisition of DNA Chip Research Shares

Mitsui Chemicals, Inc. announced the completion of its tender offer to acquire common shares of DNA Chip Research Inc. The acquisition, resolved in February 2025, involved purchasing up to 5,823,062 shares, with a minimum threshold of 3,119,000 shares. This strategic move is expected to enhance Mitsui Chemicals’ capabilities and market positioning in the biotechnology sector.

Mitsui Chemicals Enhances Governance with Structural Changes

Mitsui Chemicals has announced the abolition of its Senior Advisor and Advisor system, aiming to improve management transparency and effectiveness. Additionally, the company will change the chairperson of its Nomination Committee to an independent outside director, enhancing the fairness and objectivity of its nomination process.

Mitsui Chemicals Launches Employee Incentive Plan with Treasury Share Disposal

Mitsui Chemicals has announced the establishment of a Restricted Stock Incentive Plan aimed at its Employee Shareholding Association. This plan involves the disposal of 1,245,000 treasury shares as restricted stock to incentivize employees, aligning their interests with shareholders and promoting long-term corporate value. The initiative is designed to enhance asset-building opportunities for employees while fostering shared value creation with stakeholders.